Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Cel-Sci receives MIPS award to support TB vaccine development

Feb. 2, 2000

Nexell acquires access to Diaclone antibodies for use in cell therapy

Feb. 2, 2000

Application of Ariad's Dimerizer Drug technology covered by two U.S. patents

Jan. 31, 2000

Intranasal IL-12 is a potent adjuvant for enhancing antiviral immunity

Jan. 28, 2000

PADRE technology shows promise as universal vaccine immune stimulant

Jan. 26, 2000

North American Vaccine submits NeisVac-C for U.K. approval

Jan. 25, 2000

Peptide Therapeutics' C. difficile vaccine: positive phase I/II results

Jan. 25, 2000

Pfizer presents new series of JAK3 inhibitors for autoimmune diseases

Jan. 24, 2000

SmithKline Beecham signs CpG DNA immune stimulant agreement

Jan. 21, 2000

North American Vaccine to seek NeisVac-C approval in U.K. shortly

Jan. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...